secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0000105770-24-000075
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma Q3 EPS $1.85 (down from $2.14); raises FY2024 guidance, boosts dividend 5%
--------------------------------------------------------------------------------

- Q3 net sales $746.9M flat YoY; reported EPS $1.85 vs $2.14; adjusted EPS $1.85 vs $2.16.
- FY2024 guidance raised: net sales $2.875B-$2.905B, adjusted EPS $6.55-$6.75 (prior $6.35-$6.65).
- Dividend increased 5% to $0.21/share, payable Nov 20, 2024, record Nov 13, 2024.
- Proprietary Products net sales $601.4M (-0.2%); Contract-Manufactured $145.5M (+0.4%).
- Nine-month free cash flow $191.2M (-32.7%); share repurchases $506.5M in 9M 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/0000105770-24-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/wst-20241024.htm
  HTML page:      https://secwatch.observer/filing/0000105770-24-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer